- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OPTIMA MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,492 | -5,77 % | Aurora Cannabis Aktie: Ein neuer Lichtblick! | Der kanadische Cannabisproduzent positioniert sich durch internationale Markterschließung, technologische Innovation und solide Finanzlage für langfristiges Wachstum. Aurora Cannabis zieht weiterhin... ► Artikel lesen | |
| CANOPY GROWTH | 0,750 | -11,24 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| TILRAY BRANDS | 0,423 | -20,43 % | Tilray outlines $850M-$900M revenue target for FY2025 amid strategic growth initiatives | ||
| ABBOTT LABORATORIES | 111,48 | -2,54 % | Abbott bolsters its Heart Failure leadership | ||
| SINOPHARM | 2,025 | +1,25 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL AUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE YEAR ENDED 31 DECEMBER 2024 | ||
| AMARIN | 0,382 | +0,53 % | Amarin adds investment expert Michael Torok to Board | ||
| ACADIA PHARMACEUTICALS | 13,300 | -0,82 % | Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study... ► Artikel lesen | |
| BRIDGEBIO PHARMA | 27,460 | -2,35 % | BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM | Acoramidis's hazard ratio of.41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM patients achieved statistical significance in a pre-specified analysisThis... ► Artikel lesen | |
| CNBX PHARMACEUTICALS | - | - | CNBX Pharmaceuticals Inc. - 10-Q, Quarterly Report | ||
| AURINIA PHARMACEUTICALS | 6,874 | -1,21 % | Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS Growth and AUR200 Development | ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the third quarter and nine months... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,095 | +14,55 % | Argent BioPharma's CannEpil Approved in Germany | ||
| CENTR BRANDS | 0,001 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 19.11.2024 | The following instruments on XETRA do have their first trading 19.11.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 19.11.2024
Aktien
1 US76200L3096 Rezolute Inc.
2 ES0105848008... ► Artikel lesen | |
| LABORATORIOS FARMACEUTICOS ROVI | 46,020 | -2,46 % | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Liquidity contract: transactions conducted in the first quarter of 2025 | ||
| AVECHO BIOTECHNOLOGY | 0,002 | +50,00 % | Avecho Biotechnology: Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia | Highlights:
Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho... ► Artikel lesen | |
| HERON THERAPEUTICS | 1,631 | -8,93 % | Heron Therapeutics, Inc.: Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates | Achieved Q4 2024 GAAP Net Income of $3.6 million
Generated full-year 2024 Net Revenue of $144.2 million, up 14% year-over-year
Delivered full-year 2024 adjusted... ► Artikel lesen |
OPTIMA MEDICAL INNOVATIONS CORP gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTIMA MEDICAL INNOVATIONS CORP finden Sie auf Wallstreet Online.
